EUVIMEDEUVIMED entdecken
Crossref

A single-center retrospective series of OCT and MRI findings in pediatric MOGAD optic neuritis patients

Ridhima Guniganti, Shinji Rho, Juan F Morales-Leόn, Soe Mar, Andrew Lee, Manu Goyal, Margaret M Reynolds, Gregory P Van Stavern

Canadian Journal of Ophthalmology · 2025

DOI: 10.1016/j.jcjo.2024.07.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Ophthalmology, 2025. Verfasst von Ridhima Guniganti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Visual Sciences, Washington University in St Louis, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Tomography, Optical Coherence, Optic Neuritis, Magnetic Resonance Imaging, Visual Acuity. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Whether optical computed tomography (OCT) and magnetic resonance imaging (MRI) findings are associated with final visual acuity in children with myelin oligodendrocyte glycoprotein antibody disease (MOGAD) optic neuritis is unclear. METHODS: We retrospectively reviewed the charts of pediatric patients with MOGAD optic neuritis seen at St. Louis Children's Hospital/Barnes Jewish Hospital since 2016. RESULTS: In the 12 patients in this study, presenting visual acuity was worse in the optic neuritis-affected eyes but significantly improved from presentation to follow-up, such that, at last follow-up, there was no longer a statistical difference between the affected and unaffected eyes. The number of affected eyes with nerve enhancement and the amount of optic nerve affected, as well as thickness of the retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), and macula, decreased from presentation to follow-up. Ultimately, none of these variables were associated with final visual acuity. CONCLUSION: In this cohort, pediatric MOGAD optic neuritis patients had positive visual outcomes despite significant RNFL thinning and involvement of the optic nerve on MRI, leading to a lack of correlation between follow-up visual acuity and OCT and MRI measures of disease severity, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tomography, Optical CoherenceOptic NeuritisMagnetic Resonance ImagingVisual AcuityMyelin-Oligodendrocyte GlycoproteinRetinal Ganglion CellsAutoantibodiesOptic NerveHumansRetrospective StudiesFemaleMaleChildAdolescentFollow-Up StudiesNerve FibersChild, PreschoolMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Substanzen

Myelin-Oligodendrocyte GlycoproteinAutoantibodies

Autor:innen und Institutionen

  • Department of Ophthalmology & Visual Sciences, Washington University in St Louis, St. Louis, MO, USA.
  • Mallinckrodt Institute of Radiology, Washington University in St Louis, St. Louis, MO, USA.
  • Division of Pediatric & Developmental Neurology, Department of Neurology, St Louis Children's Hospital, St. Louis, MO, USA.
  • Department of Ophthalmology & Visual Sciences, Washington University in St Louis, St. Louis, MO, USA. Electronic address: vanstaverng@wustl.edu.

Zitieren

APA

Guniganti, R., Rho, S., Morales-Leόn, J. F., Mar, S., Lee, A., Goyal, M., Reynolds, M. M., & Van Stavern, G. P. (2025). A single-center retrospective series of OCT and MRI findings in pediatric MOGAD optic neuritis patients. Canadian Journal of Ophthalmology. https://doi.org/10.1016/j.jcjo.2024.07.021

Vancouver

Guniganti R, Rho S, Morales-Leόn JF, Mar S, Lee A, Goyal M, et al. A single-center retrospective series of OCT and MRI findings in pediatric MOGAD optic neuritis patients. Canadian Journal of Ophthalmology. 2025. doi:10.1016/j.jcjo.2024.07.021

BibTeX
@article{Guniganti2025,
  author = {Guniganti, Ridhima and Rho, Shinji and Morales-Leόn, Juan F and Mar, Soe and Lee, Andrew and Goyal, Manu and Reynolds, Margaret M and Van Stavern, Gregory P},
  title = {A single-center retrospective series of OCT and MRI findings in pediatric MOGAD optic neuritis patients},
  journal = {Canadian Journal of Ophthalmology},
  year = {2025},
  doi = {10.1016/j.jcjo.2024.07.021}
}
Kostenlos starten →